(Press-News.org) UPTON, NY-Scientists at the U.S. Department of Energy's Brookhaven National Laboratory have identified two promising candidates for the development of drugs against human adenovirus, a cause of ailments ranging from colds to gastrointestinal disorders to pink eye. A paper published in FEBS Letters, a journal of the Federation of European Biochemical Societies, describes how the researchers sifted through thousands of compounds to determine which might block the effects of a key viral enzyme they had previously studied in atomic-level detail.
"This research is a great example of the potential for rational drug design," said lead author Walter Mangel, a biologist at Brookhaven Lab. "Based on studies of the atomic-level structure of an enzyme that's essential for the maturation of adenovirus and how that enzyme becomes active-conducted at Brookhaven's National Synchrotron Light Source (NSLS)-we used computational modeling to search for compounds that might interfere with this enzyme and tested the best candidates in the lab."
Out of 140,000 compounds in a national database, the scientists identified two they expect to be able to turn into antiviral agents to combat adenovirus.
The need for such antiviral compounds stems from the diversity of human adenoviruses and their ubiquitous effects, Mangel said. Adenoviruses cause many types of respiratory diseases (including outbreaks among military recruits), childhood pneumonias, and eye infections-and may even play a role in obesity. They are particularly dangerous for individuals with impaired immunity, such as transplant recipients and patients with AIDS.
With more than 50 varieties causing this range of diseases, it's unlikely scientists will develop a universally effective vaccine to prevent all strains of adenovirus before infection, Mangel said. But one thing all adenovirus strains share is a common mechanism of making new virus particles once an infection takes root. Targeting that mechanism with antiviral drugs-the approach taken by the Brookhaven team-may be a viable way to battle all adenovirus strains.
Mangel worked with fellow Brookhaven scientists William McGrath and Vito Graziano, along with Kathy Zabrocka, a student from Stanford University who was conducting an undergraduate internship in his lab. The research built on work Mangel's lab initiated years earlier to decipher the atomic-level structure of the adenovirus proteinase, an enzyme conserved throughout all strains of the virus that cleaves proteins during the assembly of new virus particles.
"Once those proteins are cleaved, the newly synthesized virus particle is infectious," Mangel explained. "If those proteins are not cleaved, then the infection is aborted. Thus, inhibitors of the adenovirus proteinase should be effective antiviral agents against all strains of adenovirus," he said.
Over several years, Mangel's group found that the activity of the enzyme was highly regulated by two cofactors, a small piece of another adenovirus protein and the viral DNA. Structures of the enzyme alone and in the presence of its cofactors, determined by x-ray crystallography at the NSLS, revealed key regions that could serve as potential targets for blocking the enzyme's activation or protein-cleaving ability.
"All that remained was to find compounds that bind to these targets to prevent the enzyme from functioning," Mangel said.
To find these compounds, the scientists used a technique called DOCKing, which entails computationally probing a region of the protein structure against databases of small molecules to determine which might bind most strongly. Out of a database of 140,000 potential compounds, the scientists identified 30 molecules predicted to fit best and ordered samples to test for inhibitor activity.
Two of the molecules that DOCKing identified turned out to be excellent inhibitors of the adenovirus proteinase. At the concentrations that inhibited the adenovirus proteinase, these same compounds did not inhibit other, similar enzymes. Thus, the compounds appear to be specific inhibitors of the adenovirus enzyme.
The molecules identified are still too large to be delivered as drugs. So the scientists are working to pare down the size in the design of a second-generation compound based upon the binding portions of the two inhibitors. This new molecule is expected to readily enter adenovirus-infected cells and bind even more tightly to the adenovirus proteinase.
"This work should pave the way for the development of effective drugs against all types of adenovirus infections," Mangel said.
###
This research was supported by the National Institutes of Health (grant number AI R0141599). The National Synchrotron Light Source at Brookhaven is supported by the DOE Office of Science. Beamlines x25 and x29, used in the prior structural studies, were supported by the DOE Office of Science and by the National Center for Research Resources (P41RR012408) and the National Institute of General Medical Sciences (P41GM103473) of the National Institutes of Health.
Related Links
Scientific paper: First generation inhibitors of the adenovirus proteinase
Enzyme Studies at Brookhaven Lab May Lead to New Antiviral Agents
New Approach to Anti-Viral Therapy May Help Overcome Drug Resistance
First Glimpse of DNA Binding to Viral Enzyme
One of ten national laboratories overseen and primarily funded by the Office of Science of the U.S. Department of Energy (DOE), Brookhaven National Laboratory conducts research in the physical, biomedical, and environmental sciences, as well as in energy technologies and national security. Brookhaven Lab also builds and operates major scientific facilities available to university, industry and government researchers. Brookhaven is operated and managed for DOE's Office of Science by Brookhaven Science Associates, a limited-liability company founded by the Research Foundation for the State University of New York on behalf of Stony Brook University, the largest academic user of Laboratory facilities, and Battelle, a nonprofit applied science and technology organization.
Scientists identify promising antiviral compounds
Structural details and computational modeling may lead to rational design of drugs to combat adenovirus
2013-07-02
ELSE PRESS RELEASES FROM THIS DATE:
Controlling blood pressure, cholesterol may significantly cut heart disease risk
2013-07-02
Simultaneously controlling your high blood pressure and high cholesterol may cut your risk for heart disease by half or more, according to new research in the American Heart Association journal Circulation. Yet fewer than one in three people achieve this goal.
Researchers also found:
Prescribing medications to better manage blood pressure and cholesterol would greatly benefit people who are older, diabetic, have cardiovascular disease or are Hispanic or African-American.
Going to the doctor at least twice a year could help.
Undertreated high blood pressure and cholesterol ...
Nuke test radiation can fight poachers
2013-07-02
SALT LAKE CITY, July 1, 2013 – University of Utah researchers developed a new weapon to fight poachers who kill elephants, hippos, rhinos and other wildlife. By measuring radioactive carbon-14 deposited in tusks and teeth by open-air nuclear bomb tests, the method reveals the year an animal died, and thus whether the ivory was taken illegally.
"This could be used in specific cases of ivory seizures to determine when the ivory was obtained and thus whether it is legal," says geochemist Thure Cerling, senior author of a study about the new method. It was published online ...
New forensic technique may help track illegal ivory
2013-07-02
Nearly 25 years after an international ban was placed on ivory, African elephants are being slaughtered at a rate that could bring about their extinction this century. By allowing the trade of ivory acquired before 1989 to continue, the ban put the burden on law enforcement to distinguish between legal ivory and poached. Now, a new method for dating elephant tusks, described in the latest issue of the Proceedings of the National Academy of Sciences (PNAS), could make it easier to enforce the ivory ban and save the African elephant from extermination say researchers. The ...
Yale team finds protein essential for cognition -- and mental health
2013-07-02
The ability to maintain mental representations of ourselves and the world — the fundamental building block of human cognition — arises from the firing of highly evolved neuronal circuits, a process that is weakened in schizophrenia. In a new study, researchers at Yale University School of Medicine pinpoint key molecular actions of proteins that allow the creation of mental representations necessary for higher cognition that are genetically altered in schizophrenia. The study was released July 1 in the Proceedings of the National Academy of Sciences.
Working memory, the ...
Inactivation of taste genes causes male sterility
2013-07-02
PHILADELPHIA (July 01, 2013) – Scientists from the Monell Center report the surprising finding that two proteins involved in oral taste detection also play a crucial role in sperm development.
"This paper highlights a connection between the taste system and male reproduction," said lead author Bedrich Mosinger, MD, PhD, a molecular biologist at Monell. "It is one more demonstration that components of the taste system also play important roles in other organ systems."
While breeding mice for taste-related studies, the researchers discovered that they were unable to ...
WSU researchers create superconductor from solvent
2013-07-02
PULLMAN, Wash.—A study led by Washington State University researchers has turned a fairly common non-metallic solvent into a superconductor capable of transmitting electrical current with none of the resistance seen in conventional conductors.
"It is an important discovery that will attract a lot of attention from many scientific communities—physics, chemistry, and materials science," said Choong-Shik Yoo, a professor of chemistry and Institute for Shock Physics. The National Science Foundation-funded discovery, which grows out of research by Yoo doctoral student Ranga ...
Improving crop yields in a world of extreme weather events
2013-07-02
RIVERSIDE, Calif. — Farmers in the United States witnessed record-breaking extremes in temperature and drought during the last two summers, causing worldwide increases in the costs of food, feed and fiber. Indeed, many climate scientists caution that extreme weather events resulting from climate change is the new normal for farmers in North America and elsewhere, requiring novel agricultural strategies to prevent crop losses.
Now a research team led by Sean Cutler, a plant cell biologist at the University of California, Riverside, has found a new drought-protecting chemical ...
Age affects how married couples handle conflict
2013-07-02
SAN FRANCISCO, July 1, 2013 -- Arguing with your spouse about where to go on vacation or how to handle the kids? As you age, you may find yourself handling these disagreements more often by changing the subject, according to a new San Francisco State University study.
The study by Sarah Holley, SF State assistant professor of psychology who directs the University's Relationships, Emotion and Health Lab, followed 127 middle-aged and older long-term married couples across 13 years, checking in to see how they communicated about conflicts from housework to finances. The researchers ...
Hearing loss from loud blasts may be treatable, Stanford researchers say
2013-07-02
STANFORD, Calif. — Long-term hearing loss from loud explosions, such as blasts from roadside bombs, may not be as irreversible as previously thought, according to a new study by researchers at the Stanford University School of Medicine.
Using a mouse model, the study found that loud blasts actually cause hair-cell and nerve-cell damage, rather than structural damage, to the cochlea, which is the auditory portion of the inner ear. This could be good news for the millions of soldiers and civilians who, after surviving these often devastating bombs, suffer long-term hearing ...
Study suggests quality initiatives needed to reduce repeat lipid testing
2013-07-02
An analysis of patients with coronary heart disease (CHD) who attained low-density lipoprotein cholesterol (LDL-C) goals with no treatment intensification suggests that about one-third of them underwent repeat testing, according to a report published by JAMA Internal Medicine, a JAMA Network publication.
The authors note in the study background that the frequency and correlates of repeat lipid testing in patients with CHD who have already achieved Adult Treatment Panel III guideline-recommended LDL-C treatment targets and received no treatment intensification are unknown. ...
LAST 30 PRESS RELEASES:
CeSPIACE: A broad-spectrum peptide inhibitor against variable SARS-CoV-2 spikes
Understanding the origin of magnetic moment enhancement in novel alloys
BU researchers develop computational tools to safeguard privacy without degrading voice-based cognitive markers
Breakthrough in rapid polymer nanostructure production
Artificial photosynthesis: Researchers mimic plants
Social disadvantage can accelerate ageing and increase disease risk
Breaking free from dependence on rare resources! A domestic high-performance permanent magnet emerges!
Symptoms of long-COVID can last up to two years after infection with COVID-19
Violence is forcing women in Northern Ireland into homelessness, finds new report
Latin American intensivists denounce economic and cultural inequities in the global scientific publishing system
Older adults might be more resistant to bird flu infections than children, Penn research finds
Dramatic increase in research funding needed to counter productivity slowdown in farming
How chemistry and force etch mysterious spiral patterns on solid surfaces
Unraveling the mysteries of polycystic kidney disease
Mother’s high-fat diet can cause liver stress in fetus, study shows
Weighing in on a Mars water debate
Researchers ‘seq’ and find a way to make pig retinal cells to advance eye treatments
Re-purposed FDA-approved drug could help treat high-grade glioma
Understanding gamma rays in our universe through StarBurst
Study highlights noninvasive hearing aid
NASA taps UTA to shape future of autonomous aviation
Mutations disrupt touch-based learning, study finds
Misha lived in zoos, but the elephant’s tooth enamel helps reconstruct wildlife migrations
Eat better, breathe easier? Research points to link between diet, lung cancer
Mesozoic mammals had uniform dark fur
Wartime destruction of Kakhovka Dam in Ukraine has long-term environmental consequences
NIH’s flat 15% funding policy is misguided and damaging
AI reveals new insights into the flow of Antarctic ice
Scientists solve decades-long Parkinson’s mystery
Spinning, twisted light could power next-generation electronics
[Press-News.org] Scientists identify promising antiviral compoundsStructural details and computational modeling may lead to rational design of drugs to combat adenovirus